Called Stealth AXiS, the surgical system builds on Medtronic’s Mazor robotic platform, as the medical device maker takes market share in the $15 billion cranial and spinal technologies sector.

Patients needing spine surgery at Augusta Health now have access to advanced robotic technology that enhances accuracy and safety.

The medical technology behemoth will now be selling the smaller firm's Renaissance robotic surgery system, which could move the needle for Mazor, and possibly get it in the black for the first time.

Medtronic (NYSE:MDT) announced today that it received FDA clearance for its Stealth AXiS robotic system for spine surgery.

Mazor Robotics Ltd., a leading developer of innovative bone mounted surgical robotic guidance systems, today entered into two strategic agreements with Medtronic plc (NYSE: MDT). One agreement is a ...